RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 137 filers reported holding RELAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,289,321 | -19.1% | 153,308 | +20.8% | 0.00% | – |
| Q2 2023 | $1,593,662 | +30.8% | 126,884 | +71.6% | 0.00% | – |
| Q1 2023 | $1,218,005 | +38.5% | 73,953 | +25.6% | 0.00% | – |
| Q4 2022 | $879,488 | -32.0% | 58,868 | +1.8% | 0.00% | – |
| Q3 2022 | $1,294,000 | +34.0% | 57,807 | +0.3% | 0.00% | – |
| Q2 2022 | $966,000 | -39.5% | 57,619 | +8.1% | 0.00% | – |
| Q1 2022 | $1,596,000 | +74.0% | 53,326 | +78.7% | 0.00% | – |
| Q4 2021 | $917,000 | +6.1% | 29,835 | +8.9% | 0.00% | – |
| Q3 2021 | $864,000 | +1.4% | 27,395 | +17.7% | 0.00% | – |
| Q2 2021 | $852,000 | +158.2% | 23,277 | +143.7% | 0.00% | – |
| Q1 2021 | $330,000 | +13.4% | 9,552 | +36.4% | 0.00% | – |
| Q4 2020 | $291,000 | – | 7,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |